Making a Good First Impression: Launch Messages in an Era of REMS
This article was originally published in RPM Report
Executive Summary
When FDA took the unusual step of reprimanding a clinical investigator for promoting a newly approved botulinum toxin brand, the agency stressed its over-riding concern about the "first impression" of a new product in marketing messages Commercial sponsors should pay attention: just ask King.